CGTX · Cognition Therapeutics Inc · Documents
$0.78
+0.02 (+2.53%)
At close · Oct 28
Return incl. dividend (before tax)
Q4 2024 earnings call transcript
Market Cap
$72.19M
Shares
95.09M
Volume · Oct 28
14.48K
Avg daily vol (3M)
516.43K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEFA14A | — | 2022-04-25 | — | |
| DEF 14A | — | 2022-04-25 | 2022-06-10 | |
| 10-K | — | 2022-03-30 | 2021-12-31 | |
| 8-K | — | 2022-03-30 | — | |
| 8-K | — | 2022-03-15 | — | |
| 8-K | — | 2022-01-10 | — | |
| 8-K | — | 2021-11-18 | — | |
| 10-Q | — | 2021-11-17 | 2021-09-30 | |
| 8-K | — | 2021-11-12 | 2021-11-10 | |
| 8-K | — | 2021-11-03 | 2021-10-29 | |
| 8-K | — | 2021-10-14 | 2021-10-13 | |
| S-1/A | — | 2021-10-04 | — | |
| S-1/A | — | 2021-09-10 | — | |
| S-1/A | — | 2021-08-20 | — | |
| S-1/A | — | 2021-07-29 | — | |
| S-1 | — | 2021-07-19 | — |
Showing 101–116 of 116 filings
Key facts
CIK
1455365
CUSIP
19243B102
13F (30d)
14 filings
14 filers
Visit website
Investor relations